International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
We are currently experiencing multidisciplinarity in research as well as in the treatment of inflammatory and oncological diseases. Precision treatment would be impossible without an interdisciplinary approach, bringing together specialists in many fields. Multidisciplinary teams are being formed, bringing together clinicians, pathomorphologists, molecular biologists, radiation oncologists, surgeons and skilled medical personnel to make the most accurate therapeutic decisions. This approach is most evident in oncology. These interdisciplinary teams may be expanded to include members involved in microbiota profiling. The microbiota appears essential in the onset and course of inflammatory diseases that can lead to cancer. The composition and diversity of the microbiota may also determine the effectiveness of personalized treatment. More and more data indicate that the microbiota assessment may be used in everyday clinical practice to enable more precise treatment.